Charles is global co-head of our private capital group. He specialises in high-profile and complex acquisitions, carve-outs, take-privates and exits for some of the world’s largest financial sponsors.
Charles is sought after by clients who value his technical and commercial excellence on a full range of financial sponsor deal types. He works across sectors, specialising in financial services, media and healthcare. He has also advised on a number of high-profile sports investments.
His client base covers global private equity houses, pension funds, sovereign wealth funds and corporates. Having spent time on secondment with Goldman Sachs and in Freshfields’ MENA offices, Charles has a thorough understanding of the needs of our global financial sponsor clients.
Charles speaks English, French and German.
- SURJ Sports Investment Company on its acquisition of a minority stake in DAZN Group Limited, a leading global sports streaming and entertainment company;
- Permira on its agreement for recommended cash offer for Ergomed plc, a public-to-private acquisition in the pharma sector;
- CVC on its IPO on the Amsterdam Stock Exchange;
- CVC on its carve-out acquisition of the Therakos business from global specialty pharma company Mallinckrodt;
- CVC on its acquisition of leading infrastructure manager DIF;
- CVC and its portfolio company Stock Spirits group, on the entry into exclusive negotiations for the simultaneous acquisitions of the Clan Campbell Blended Scotch Whisky brand and The Dugas Group;
- CVC on its strategic partnership with Women’s Tennis Association (“WTA”);
- CVC in connection with Partners Group’s increased investment in Breitling;
- CVC on the sale of Etraveli Group to Booking Holdings Inc for €1.63bn;
- CVC on the acquisition of ekaterra B.V., the holding company of Unilever’s global tea business for €4.5bn;
- CVC on the acquisition of a majority interest in Medivet, a leading veterinary care provider in the UK, Germany and Spain;
- CVC on its acquisition of a majority interest in Rayner Surgical Group Limited, the global ophthalmology business;
- CVC on its acquisition of a majority interest in System C Healthcare, the UK’s leading health and social care software company. The transaction also encompasses a minority interest in Graphnet Health, the UK’s leading supplier of shared care record software and population health data solutions to the NHS;
- CVC Capital Partners on its acquisition of Glendower Capital, a private equity firm focussing on secondary transactions which spun out of Deutsche Bank’s asset management business in 2017;
- RAC, CVC Capital Partners and GIC on the sale of a stake in RAC to Silver Lake Partners; Silver Lake will become a co-shareholder alongside the RAC’s existing shareholders, including GIC and funds managed or advised by CVC Capital Partners;
- Advising CVC on its participation with Fédération de Internationale Volleyball (“FIVB”) and partnership in Volleyball World;
- Advising GIC on an investment made by their venture capital team into Checkout.com;
- Advising CVC on its partnerships with Premiership Rugby and Pro14 Rugby;
- Advising CVC on the proposed take-private of Nasdaq Stockholm-listed Ahlsell AB by CVC Fund VII in an offer that values Ahlsell at USD 2.65 billion;
- Advising CVC and Messer Industries on the acquisition of the US divestment assets of Linde and Praxair following the announcement of those parties’ intention to merge;
- Advising on the acquisition of TMF Group, a leading provider of specialist business services to clients operating and investing globally, from DH Private Equity Partners, for €1.75bn.
100 Bishopsgate